Iterum Therapeutics Plc (ITRM) Tops Q1 EPS by 60c

Iterum Therapeutics Plc (NASDAQ: ITRM) reported Q1 EPS of ($0.58), $0.60 better than the analyst estimate of ($1.18).

For earnings history and earnings-related data on Iterum Therapeutics Plc (ITRM) click here.

You May Also Be Interested In

• Full Truck Alliance (YMM) Tops Q2 EPS by 10c; beats on guidance
• Taylor Devices (TAYD) Misses Q4 EPS by 31c
• Corporación América Airports S.A. (CAAP) Misses Q2 EPS by 18c